Adrovic A, Yildiz M, Haslak F, Sahin S, Koker O, Gunalp A
Arch Rheumatol. 2023; 38(2):267-273.
PMID: 37680509
PMC: 10481691.
DOI: 10.46497/ArchRheumatol.2023.9636.
Hoffmann-Vold A, Distler O, Bruni C, Denton C, de Vries-Bouwstra J, Cerinic M
Lancet Rheumatol. 2022; 4(8):e566-e575.
PMID: 35891634
PMC: 9302939.
DOI: 10.1016/S2665-9913(22)00130-8.
Pelechas E, Drossou V, Voulgari P, Drosos A
Mediterr J Rheumatol. 2022; 33(1):68-74.
PMID: 35611100
PMC: 9092100.
DOI: 10.31138/mjr.33.1.68.
Denton C, Campochiaro C, Bruni C, Distler O, Iagnocco A, Cerinic M
J Scleroderma Relat Disord. 2022; 6(1):58-65.
PMID: 35382249
PMC: 8922634.
DOI: 10.1177/2397198320963393.
Spencer K, Singer E, Girda E
J Cancer Biol. 2022; 2(3):75-82.
PMID: 35224563
PMC: 8870506.
DOI: 10.46439/cancerbiology.2.029.
Insight into COVID-19's epidemiology, pathology, and treatment.
Aimrane A, Ait Laaradia M, Sereno D, Perrin P, Draoui A, Bougadir B
Heliyon. 2022; 8(1):e08799.
PMID: 35071819
PMC: 8767941.
DOI: 10.1016/j.heliyon.2022.e08799.
COVID-19 and Autoimmune/Autoinflammatory Rheumatic Disease Patients: Lessons Learned and Questions Anticipating Answers.
Bakasis A, Moutsopoulos H
Mediterr J Rheumatol. 2021; 32(3):188-191.
PMID: 34964022
PMC: 8693296.
DOI: 10.31138/mjr.32.3.188.
Effects of statins and steroids on coronary artery disease and stroke in patients with interstitial lung disease and pulmonary fibrosis: A general population study.
Yeh J, Lin C, Hsu N, Kao C
PLoS One. 2021; 16(10):e0259153.
PMID: 34705851
PMC: 8550436.
DOI: 10.1371/journal.pone.0259153.
Humoral Response to SARS-CoV-2 Vaccine of a Patient Receiving Methotrexate Treatment and Implications for the Need of Monitoring.
Lukaszuk K, Woclawek-Potocka I, Jakiel G, Malinowska P, Wdowiak A, Rozanska K
Vaccines (Basel). 2021; 9(10).
PMID: 34696259
PMC: 8541181.
DOI: 10.3390/vaccines9101151.
COVID-19 Immunobiology: Lessons Learned, New Questions Arise.
Kaklamanos A, Belogiannis K, Skendros P, Gorgoulis V, Vlachoyiannopoulos P, Tzioufas A
Front Immunol. 2021; 12:719023.
PMID: 34512643
PMC: 8427766.
DOI: 10.3389/fimmu.2021.719023.
COVID-19 and the Use of Immunomodulatory Agents in Ophthalmology.
Degirmenci M, Yalcindag F, Tugal-Tutkun I
Turk J Ophthalmol. 2021; 51(4):231-242.
PMID: 34461710
PMC: 8411289.
DOI: 10.4274/tjo.galenos.2021.68252.
Low symptomatic COVID-19 in an elderly patient with follicular lymphoma treated with rituximab-based immunotherapy: A case report.
Lacki S, Wyzgolik K, Nicze M, Georgiew-Nadziakiewicz S, Chudek J, Wdowiak K
World J Clin Cases. 2021; 9(18):4859-4865.
PMID: 34222459
PMC: 8223830.
DOI: 10.12998/wjcc.v9.i18.4859.
He-Jie-Shen-Shi Decoction as an Adjuvant Therapy on Severe Coronavirus Disease 2019: A Retrospective Cohort and Potential Mechanistic Study.
Hu H, Wang K, Wang L, Du Y, Chen J, Li Y
Front Pharmacol. 2021; 12:700498.
PMID: 34220524
PMC: 8250425.
DOI: 10.3389/fphar.2021.700498.
Autoimmune connective tissue diseases in the COVID-19 pandemic.
Dourmishev L, Guleva D, Pozharashka J, Drenovska K, Miteva L, Vassileva S
Clin Dermatol. 2021; 39(1):56-63.
PMID: 33972054
PMC: 7833035.
DOI: 10.1016/j.clindermatol.2020.12.013.
.
Ng T, Leblanc K, Yeung D, Tsang T
Can Fam Physician. 2021; 67(3):e69-e78.
PMID: 33727386
PMC: 7963008.
DOI: 10.46747/cfp.6703e69.
Medication use during COVID-19: Review of recent evidence.
Ng T, Leblanc K, Yeung D, Tsang T
Can Fam Physician. 2021; 67(3):171-179.
PMID: 33727376
PMC: 7963004.
DOI: 10.46747/cfp.6703171.
Pharmacological mechanism of immunomodulatory agents for the treatment of severe cases of COVID-19 infection.
Bahari Z, Jangravi Z, Ghoshooni H, Afarinesh M, Meftahi G
Inflamm Res. 2021; 70(4):389-405.
PMID: 33608746
PMC: 7894237.
DOI: 10.1007/s00011-021-01445-2.
"Tocilizumab-an option for patients with COVID-19 associated cytokine release syndrome: A single center experience", a retrospective study-original article.
Khan Chachar A, Khan K, Iqbal J, Shahid A, Asif M, Fatima S
Ann Med Surg (Lond). 2021; 63:102165.
PMID: 33585031
PMC: 7869677.
DOI: 10.1016/j.amsu.2021.02.011.
Gastrointestinal symptoms, pathophysiology, and treatment in COVID-19.
Zhang J, Garrett S, Sun J
Genes Dis. 2021; 8(4):385-400.
PMID: 33521210
PMC: 7836435.
DOI: 10.1016/j.gendis.2020.08.013.
COVID-19 in Immunocompromised Hosts: What We Know So Far.
Fung M, Babik J
Clin Infect Dis. 2021; 72(2):340-350.
PMID: 33501974
PMC: 7337668.
DOI: 10.1093/cid/ciaa863.
